Medical expenditure for lung cancer in China: a multicenter, hospital-based retrospective survey

Medical expenditure for lung cancer in China: a multicenter, hospital-based retrospective survey

Abstract Background Lung cancer is the most prevalent cancer, and the leading cause of cancer-related deaths in China. The aim of this study was to estimate the direct medical expenditure incurred for lung cancer care and analyze the trend therein for the period 2002–2011 using nationally representa...

Full description

Bibliographic Details
Main Authors: Xin Zhang, Ju-Fang Shi, Guo-Xiang Liu, Jian-Song Ren, Lan-Wei Guo, Wei-Dong Huang, Lin-Mei Shi, Yi Ma, Hui-Yao Huang, Ya-Na Bai, Xian-Zhen Liao, A-Yan Mao, Xiao-Jie Sun, Xin-Yu Zhu, Qi Zhou, Ji-Yong Gong, Jin-Yi Zhou, Yu-Qin Liu, Ling Mai, Bing-Bing Song, Lin Zhu, Xiao-Jing Xing, Ling-Bin Du, Xiao Qi, Xiao-Hua Sun, Shou-Ling Wu, Ying Ren, Rong Cao, Li Lan, Pei-An Lou, Kai Zhang, Jie He, Min Dai
Format: Article
Language:English
Published: BMC 2021-08-01
Series:Cost Effectiveness and Resource Allocation
Subjects:
Lung cancer
Medical expenditure
Cost
China
Online Access:https://doi.org/10.1186/s12962-021-00306-3

Internet

https://doi.org/10.1186/s12962-021-00306-3

Similar Items